Crux Biomedical

Crux Biomedical Overview

Founded 2004
Status Acquired/​Merged
Latest Deal Type M&A
Latest Deal Amount $39M
Latest Deal Amount
Investors 1

Crux Biomedical General Information


Developer of a preventive device for pulmonary embolisms. The company provide Crux VCF System, that stops the blood clots from reaching the lungs. It is useful for patients at risk of pulmonary embolism who can't tolerate blood thinners, method of preventing clots.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Primary Office
  • 1455 Adams Drive
  • Suite 1170
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crux Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 12-Dec-2012 $39M 000.00 0000 Completed Generating Revenue
6. Later Stage VC (Series D) 07-Jun-2011 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Mar-2011 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 22-Jan-2009 000 000.00 Completed Generating Revenue
3. Later Stage VC 08-Dec-2008 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 02-Oct-2007 $2.25M $6.1M Completed Generating Revenue
1. Early Stage VC (Series A) 18-Sep-2006 $3.85M $3.85M Completed Product Development

Crux Biomedical Executive Team (4)

Name Title Board Seat Contact Info
Mel Schatz President & Chief Executive Officer
Christopher Schaffer Chief Financial Officer
Murli Srinivasan Director, Operations
Eric Johnson Vice President, Research & Development

Crux Biomedical Former Investors (4)

To view Crux Biomedical‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alloy Ventures Venture Capital Minority 000 0000 000000 0
Emergent Medical Partners Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
Three Arch Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial